Caloglu, Vuslat YurutAkmansu, MugeYalman, DenizGul, Sule KarabulutKocak, ZaferAlicikus, Zumre AricanSerarslan, Alparslan2024-06-122024-06-1220220163-55811532-7914https://doi.org/10.1080/01635581.2022.2093386https://hdl.handle.net/20.500.14551/25066Cancer patients often face malnutrition, which negatively affects their response to cancer treatment. This study aims to analyze the effects of the COVID-19 pandemic on nutritional status and anxiety in cancer patients with different types and stages of cancer. This is a cross-sectional cohort study that includes 1,252 patients with varying cancer types from 17 radiation oncology centers. The nutritional risk scores (NRS-2002) and coronavirus anxiety scale (CAS) scores of all patients were measured. NRS-2002 >= 3 and CAS >= 5 were accepted as values at risk. Of all patients, 15.3% had NRS-2002 >= 3. Breast cancer was the most prevalent cancer type (24.5%) with the lowest risk of nutrition (4.9%, p < 0.001). Nutritional risk was significantly higher in patients with gastrointestinal cancer, head and neck cancer, and lung cancer (p < 0.005) and in patients with stage IV disease (p < 0.001). High anxiety levels (CAS >= 5) were significantly related to voluntary avoidance and clinical postponement of hospital visits due to the pandemic (p < 0.001), while clinical postponement was particularly frequent among patients with NRS-2002 < 3 (p = 0.0021). Fear and anxiety in cancer patients with COVID-19 cause hesitations in visiting hospitals, leading to disrupted primary and nutritional treatments. Thus, nutritional monitoring and treatment monitoring of cancer patients are crucial during and after radiotherapy.en10.1080/01635581.2022.2093386info:eu-repo/semantics/closedAccessHospital AdmissionCancer-PatientsChemotherapyMalnutritionRiskArticle741036013610Q3WOS:0008214467000012-s2.0-8513351079135792709Q2